DMAA — DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05

Ownership history in Karpus Management, Inc.  ·  3 quarters on record

This page tracks every 13F SEC filing in which Karpus Management, Inc. reported a position in DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05 (DMAA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.9% (2025 Q2)
Avg. % of fund
0.83%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,547,667 -196,442 -7.2% 0.83% $26.2M $10.27
2025 Q2 ADDED 2,744,109 +420,075 +18.1% 0.90% $28.0M $10.20
2025 Q1 INITIATED 2,324,034 — — 0.75% $23.3M $10.02
% of Fund (quarterly)    DMAA price (monthly, adj. close)

Other funds also holding DMAA

As of 2025 Q4 — sorted by position size

HEIGHTS CAPITAL MANAGEMENT, INC 2.42% Westchester Capital Management, LLC 3Y 7Y 0.73% GLAZER CAPITAL, LLC 3Y 7Y 0.5% Quarry LP 3Y 0.43% Radcliffe Capital Management, L.P. 3Y 7Y 0.31% Bulldog Investors, LLP 3Y 7Y 0.3% Polar Asset Management Partners Inc. 3Y 7Y 0.21% RIVERNORTH CAPITAL MANAGEMENT, LLC 3Y 7Y 0.2% ARISTEIA CAPITAL, L.L.C. 3Y 7Y 0.2% Governors Lane LP 3Y 7Y 0.15%
← Back to Karpus Management, Inc. Holdings